Evidence map›Paper›PMID 29129185›Full record

ArticleJournal of medical case reports2017

Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: a case report.

Salvatore Notaro, Marcello Sorrentino, Aniello Ruocco, Annalisa Notaro, Antonio Corcione, Patrizia Murino, Eugenio Piscitelli, Marianna Tamborino

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Salvatore NotaroIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy. notarosal@gmail.com.
Marcello SorrentinoIntensive Care Unit, Fatebenefratelli Hospital, Naples, Italy.
Aniello RuoccoDepartment of Pharmacology, Federico II University of Naples, Naples, Italy.
Annalisa NotaroIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.
Antonio CorcioneIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.
Patrizia MurinoIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.
Eugenio PiscitelliIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.
Marianna TamborinoIntensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.
Ospedale Monaldi · ITFatebenefratelli Hospital · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this article, we present a clinical case of refractory septic shock resulting from intestinal perforation treated with high doses of vasopressin and hydrocortisone during emergency surgery. The use of such high doses of vasopressin for this type of shock is not described in the literature. CASE PRESENTATION: A 49-year-old white woman with grade III obesity, Crohn's disease, and an intestinal perforation presented with refractory septic shock. Initially, a low dose of vasopressin was used. Then, the dosage was increased to 0.4 U/minute; in the literature, this is defined as "salvage therapy." This therapy consists of an initial load followed by a continuous infusion of hydrocortisone.

conclusionsThe significant increase in her cardiac index and stroke volume index resulted in an improvement in peripheral resistance, gas exchange, and urine output and a decrease in her heart rate, interleukin-6 level, and tumor necrosis factor-α level. The administration of high doses of vasopressin and corticosteroids was demonstrated to be safe for the immune system, to reduce the systemic inflammatory response, and to have direct cardiovascular effects. Further studies are required to examine the use of vasopressin as an initial vasopressor as well as its use in high dosages and in combination with corticosteroids.

Indexed as

Acute DiseaseAnti-Inflammatory AgentsCrohn DiseaseDrug Therapy, CombinationFemaleHumansHydrocortisoneIleocecal ValveIntestinal PerforationMiddle AgedObesity, MorbidShock, SepticTomography, X-Ray ComputedVasoconstrictor AgentsVasopressinsAnti-Inflammatory AgentsHydrocortisoneVasoconstrictor AgentsVasopressinsCorticosteroidRefractory septic shockVasopressin

Identifiers

PMID29129185
PMCPMC5682640
OpenAlexW2766055370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.